Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review.

Reid SR.

Harm Reduct J. 2009 Aug 28;6:24. doi: 10.1186/1477-7517-6-24.

2.

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.

Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use.

Lancet. 2010 Mar 20;375(9719):1014-28. doi: 10.1016/S0140-6736(10)60232-2. Epub 2010 Feb 26. Review.

PMID:
20189638
3.

HIV infection among intravenous drug users: epidemiology and risk reduction.

Des Jarlais DC, Friedman SR.

AIDS. 1987 Jul;1(2):67-76. Review.

PMID:
3130084
4.

Prevention of HIV infection among injection drug users in resource-limited settings.

Vlahov D, Robertson AM, Strathdee SA.

Clin Infect Dis. 2010 May 15;50 Suppl 3:S114-21. doi: 10.1086/651482. Review.

5.

The role of needle exchange programs in HIV prevention.

Vlahov D, Junge B.

Public Health Rep. 1998 Jun;113 Suppl 1:75-80. Review.

6.

[Current status of the female condom in Africa].

Deniaud F.

Sante. 1997 Nov-Dec;7(6):405-15. Review. French.

7.

Injection risks and HIV transmission in the Republic of South Africa.

Reid S, Van Niekerk AA.

Int J STD AIDS. 2009 Dec;20(12):816-9. doi: 10.1258/ijsa.2009.009230. Review.

PMID:
19948894
8.

Syringe exchange: HIV prevention, key findings, and future directions.

Paone D, Des Jarlais DC, Gangloff R, Milliken J, Friedman SR.

Int J Addict. 1995;30(12):1647-83. Review.

PMID:
8557411
9.

HIV and intravenous drug use.

Des Jarlais DC, Friedman SR.

AIDS. 1988;2 Suppl 1:S65-9. Review.

PMID:
3147682
10.
11.

[AIDS in Africa].

Sansone R, Carobbi S, Alloro G, Strigini P.

Ann Ig. 1989 Sep-Oct;1(5):1057-66. Review. Italian.

PMID:
2483891
12.

[The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].

Tak√°cs IG, Demetrovics Z.

Psychiatr Hung. 2009;24(4):264-81. Review. Hungarian.

PMID:
19949245
14.

Outreach-based HIV prevention for injecting drug users: a review of published outcome data.

Coyle SL, Needle RH, Normand J.

Public Health Rep. 1998 Jun;113 Suppl 1:19-30. Review.

15.

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Gillies M, Palmateer N, Hutchinson S, Ahmed S, Taylor A, Goldberg D.

BMC Public Health. 2010 Nov 23;10:721. doi: 10.1186/1471-2458-10-721. Review.

16.

Emerging HIV epidemics in Muslim countries: assessment of different cultural responses to harm reduction and implications for HIV control.

Todd CS, Nassiramanesh B, Stanekzai MR, Kamarulzaman A.

Curr HIV/AIDS Rep. 2007 Dec;4(4):151-7. Review.

PMID:
18366945
17.

Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.

Stone KA.

Harm Reduct J. 2015 Oct 16;12:32. doi: 10.1186/s12954-015-0066-x. Review.

18.

HIV prevention for injecting drug users: the first 25 years and counting.

Des Jarlais DC, Semaan S.

Psychosom Med. 2008 Jun;70(5):606-11. doi: 10.1097/PSY.0b013e3181772157. Epub 2008 Jun 2. Review.

PMID:
18519886
19.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731

Supplemental Content

Support Center